Approval · Notice of Compliance 8992 · 2007
COMBIGAN: Notice of Compliance 8992
Issued August 24, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8992
- Date
- August 24, 2007
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional claims in indications and clinical use and update to the safety information in revised pm in new format
- Therapeutic class
- Elevated intraocular pressure therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMBIGAN | Not yet assigned | — |
Medicinal ingredients
- BRIMONIDINE TARTRATE 0.2 PER
- TIMOLOL MALEATE 0.5 PER